This page shows the latest Xifaxan news and features for those working in and with pharma, biotech and healthcare.
Canadian firm now intends to grow Salix salesforce to build Xifaxan and Relistor brands. ... Xifaxan and Relistor are integral to our gastrointestinal franchise which remains a core asset for future growth potential in the hands of Valeant.".
The FDA has approved two new treatments for irritable bowel syndrome with diarrhoea (IBS-D) in the form of Actavis' Viberzi (eluxadoline) and Salix' Xifaxan (rifaximin). ... Xifaxan, an antibiotic derived from rifampin, was previously approved as
The Canadian company is banking on the future success of Salix' traveller's diarrhoea and hepatic encephalopathy therapy Xifaxan (rifaximin), which is in the final stages of FDA review for the ... Analysts have suggested Xifaxan could eventually become a
Salix would give it an entry into the gastrointestinal therapy category, bringing in products such as traveller's diarrhoea and hepatic encephalopathy therapy Xifaxan (rifaximin), as well as other products like
Adding Salix to the fold will bring in traveller's diarrhoea and hepatic encephalopathy therapy Xifaxan (rifaximin), as well as other products such as diabetes therapy Glumetza (extended-release metformin) that ... Salix is due to report full-year
The problems affected Salix' hepatic encephalopathy therapy Xifaxan (rifaximin) as well as other products such as diabetes therapy Glumetza (extended-release metformin).
More from news
Approximately 2 fully matching, plus 7 partially matching documents found.
real interest driver is Xifaxan. ... Xifaxan is currently marketed for the treatment of hepatic encephalopathy and traveller's diarrhoea and nets $750m in sales, however, should the current FDA review for an inflammatory bowel disease with
The all-cash transaction is expected to close in Q1 2014. The combined company will market 22 products, including Xifaxan (rifaximin; 2012 sales of $514.5m) and Santarus' therapy Glumetza (metformin)
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...